Insider · CIK 0002013097
Leesa Gentry
Files at RNXT (RenovoRx, Inc.). First filing -, latest -.
In brief
Leesa Gentry files SEC Form 4 as officer at RNXT (RenovoRx, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Leesa Gentry has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +128,550 | $0.00 | $0 | 128,550 | Apr 7, 2026 |
| Jul 1, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +6,619 | $0.00 | $0 | 6,619 | Jul 3, 2025 |
| Apr 14, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +26,477 | $0.00 | $0 | 26,477 | Apr 16, 2025 |
Questions about Leesa Gentry
Answered from the filings on this page, as of the latest one.
Is Leesa Gentry buying or selling?
Leesa Gentry has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Leesa Gentry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Leesa Gentry has 0.
Where does Leesa Gentry file Form 4?
Leesa Gentry has filed Form 4 at RNXT (RenovoRx, Inc.) as Chief Clinical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.